Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Cochat

Showing results (151-160 of 225) with videos related to

Pageof 23
Sort By:
Pediatric Nephrology (Berlin, Germany)|December 3, 2015
Microalbuminuria among HIV-infected antiretroviral therapy-naive children in the Democratic Republic of CongoPépé M Ekulu, Michel N Aloni, Jérôme Harambat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2010
Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndromeBenoît Cammas, Jérôme Harambat, Aurélia Bertholet-Thomas, et al.
Kidney International|September 9, 2011
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adultsAlbane Brodin-Sartorius, Marie-Josèphe Tête, Patrick Niaudet, et al.
Transplantation|October 24, 2002
A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipientsGisela Offner, Michel Broyer, Patrick Niaudet, et al.
American Journal of Medical Genetics. Part A|January 30, 2007
Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndromeElke Wühl, Jillene Kogan, Aleksandra Zurowska, et al.
Pediatric Nephrology (Berlin, Germany)|February 14, 2018
Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairmentAurélia Bertholet-Thomas, Debora Claramunt-Taberner, Ségolène Gaillard, et al.
European Journal of Pediatrics|September 9, 2018
Renal Replacement Therapy in children with severe developmental disability: guiding questions for decision-makingLore Willem, Noël Knops, Djalila Mekahli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 12, 2012
Long-term critical issues in pediatric renal transplant recipients: a single-center experienceJérôme Harambat, Bruno Ranchin, Aurélia Bertholet-Thomas, et al.
The Lancet. Oncology|September 30, 2021
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessmentEtienne Lengliné, Julien Peron, Antoine Vanier, et al.
Journal of Clinical Pharmacology|February 12, 2010
Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patientsWei Zhao, May Fakhoury, Georges Deschênes, et al.
Pageof 23

Showing results (151-160 of 225) with videos related to

Sort By:
Pageof 23
Pediatric Nephrology (Berlin, Germany)|December 3, 2015
Microalbuminuria among HIV-infected antiretroviral therapy-naive children in the Democratic Republic of CongoPépé M Ekulu, Michel N Aloni, Jérôme Harambat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2010
Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndromeBenoît Cammas, Jérôme Harambat, Aurélia Bertholet-Thomas, et al.
Kidney International|September 9, 2011
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adultsAlbane Brodin-Sartorius, Marie-Josèphe Tête, Patrick Niaudet, et al.
Transplantation|October 24, 2002
A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipientsGisela Offner, Michel Broyer, Patrick Niaudet, et al.
American Journal of Medical Genetics. Part A|January 30, 2007
Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndromeElke Wühl, Jillene Kogan, Aleksandra Zurowska, et al.
Pediatric Nephrology (Berlin, Germany)|February 14, 2018
Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairmentAurélia Bertholet-Thomas, Debora Claramunt-Taberner, Ségolène Gaillard, et al.
European Journal of Pediatrics|September 9, 2018
Renal Replacement Therapy in children with severe developmental disability: guiding questions for decision-makingLore Willem, Noël Knops, Djalila Mekahli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 12, 2012
Long-term critical issues in pediatric renal transplant recipients: a single-center experienceJérôme Harambat, Bruno Ranchin, Aurélia Bertholet-Thomas, et al.
The Lancet. Oncology|September 30, 2021
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessmentEtienne Lengliné, Julien Peron, Antoine Vanier, et al.
Journal of Clinical Pharmacology|February 12, 2010
Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patientsWei Zhao, May Fakhoury, Georges Deschênes, et al.
Pageof 23